These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12379111)

  • 1. A monomeric 3(10)-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41.
    Biron Z; Khare S; Samson AO; Hayek Y; Naider F; Anglister J
    Biochemistry; 2002 Oct; 41(42):12687-96. PubMed ID: 12379111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2F5 epitope is helical in the HIV-1 entry inhibitor T-20.
    Biron Z; Khare S; Quadt SR; Hayek Y; Naider F; Anglister J
    Biochemistry; 2005 Oct; 44(41):13602-11. PubMed ID: 16216084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gp41(659-671) HIV-1 antibody epitope: a structurally challenging small peptide.
    Zhang Y; Sagui C
    J Phys Chem B; 2014 Jan; 118(1):69-80. PubMed ID: 24359409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP; Bryson S; Nieva JL; Pai EF
    J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-affinity relationships in the gp41 ELDKWA epitope for the HIV-1 neutralizing monoclonal antibody 2F5: effects of side-chain and backbone modifications and conformational constraints.
    Tian Y; Ramesh CV; Ma X; Naqvi S; Patel T; Cenizal T; Tiscione M; Diaz K; Crea T; Arnold E; Arnold GF; Taylor JW
    J Pept Res; 2002 Jun; 59(6):264-76. PubMed ID: 12010517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody.
    Brunel FM; Zwick MB; Cardoso RM; Nelson JD; Wilson IA; Burton DR; Dawson PE
    J Virol; 2006 Feb; 80(4):1680-7. PubMed ID: 16439525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both lipid environment and pH are critical for determining physiological solution structure of 3-D-conserved epitopes of the HIV-1 gp41-MPER peptide P1.
    Coutant J; Yu H; Clément MJ; Alfsen A; Toma F; Curmi PA; Bomsel M
    FASEB J; 2008 Dec; 22(12):4338-51. PubMed ID: 18776068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, conformation, and immunogenicity of monosaccharide-centered multivalent HIV-1 gp41 peptides containing the sequence of DP178.
    Ni J; Powell R; Baskakov IV; DeVico A; Lewis GK; Wang LX
    Bioorg Med Chem; 2004 Jun; 12(12):3141-8. PubMed ID: 15158782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.
    Cardoso RM; Zwick MB; Stanfield RL; Kunert R; Binley JM; Katinger H; Burton DR; Wilson IA
    Immunity; 2005 Feb; 22(2):163-73. PubMed ID: 15723805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A template-assembled model of the N-peptide helix bundle from HIV-1 Gp-41 with high affinity for C-peptide.
    Xu W; Taylor JW
    Chem Biol Drug Des; 2007 Oct; 70(4):319-28. PubMed ID: 17937777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of the HIV gp120 C5 domain.
    Guilhaudis L; Jacobs A; Caffrey M
    Eur J Biochem; 2002 Oct; 269(19):4860-7. PubMed ID: 12354117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles.
    Schibli DJ; Montelaro RC; Vogel HJ
    Biochemistry; 2001 Aug; 40(32):9570-8. PubMed ID: 11583156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural constraints imposed by the conserved fusion peptide on the HIV-1 gp41 epitope recognized by the broadly neutralizing antibody 2F5.
    de la Arada I; Julien JP; de la Torre BG; Huarte N; Andreu D; Pai EF; Arrondo JL; Nieva JL
    J Phys Chem B; 2009 Oct; 113(41):13626-37. PubMed ID: 19754136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
    Oakes V; Torralba J; Rujas E; Nieva JL; Domene C; Apellaniz B
    Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1259-1271. PubMed ID: 29477358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR and CD studies on the conformation of a synthetic peptide containing epitopes of the human immunodeficiency virus 1 transmembrane protein gp41.
    Consonni R; Limiroli R; Longhi R; Manera E; Vecchio G; Ragona L; Siccardi AG; Zetta L
    Biopolymers; 1996 Mar; 38(3):423-35. PubMed ID: 8906976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41.
    Gorny MK; Zolla-Pazner S
    J Virol; 2000 Jul; 74(13):6186-92. PubMed ID: 10846104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
    Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
    J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization.
    Cerutti N; Loredo-Varela JL; Caillat C; Weissenhorn W
    Curr Opin HIV AIDS; 2017 May; 12(3):250-256. PubMed ID: 28422789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation.
    Dwyer JJ; Hasan A; Wilson KL; White JM; Matthews TJ; Delmedico MK
    Biochemistry; 2003 May; 42(17):4945-53. PubMed ID: 12718536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state.
    Sadler K; Zhang Y; Xu J; Yu Q; Tam JP
    Biopolymers; 2008; 90(3):320-9. PubMed ID: 18338371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.